Literature DB >> 12215728

Prevalence and incidence of arrhythmias and sudden death in heart failure.

John G F Cleland1, Sudipta Chattopadhyay, Aleem Khand, Timothy Houghton, Gerald C Kaye.   

Abstract

Patients with heart failure are prone to a variety of arrhythmias, symptomatic and asymptomatic, that are prognostically significant and have an important bearing on the management of these patients. However there are some inherent problems in assessing the frequency of these arrhythmias within a large patient population, due to a lack of uniformity in defining heart failure and the transient nature of these rhythms. Patients with heart failure commonly die suddenly. The causes of these deaths are difficult to ascertain accurately and are often presumed arrhythmic. With the advent of effective interventions to prevent sudden death, accurately defining the causal relationship between the arrhythmias and sudden death has assumed great importance to appropriately target therapy. Several attempts have been made to predict such deaths on the basis of non-invasive and invasive diagnostic investigations with variable success. In this article we review the incidence and prevalence of atrial and ventricular arrhythmias and sudden deaths in epidemiological studies, surveys and randomised control trials of patients with heart failure. We discuss the prognostic significance of these arrhythmias, the inherent problems in their diagnosis and whether their presence predicts the risk of sudden deaths and the mode of such deaths in the heart failure population. The role of various investigations in risk stratification of sudden death has also been discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12215728     DOI: 10.1023/a:1020024122726

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  114 in total

1.  Sudden death in heart failure: vascular or electrical?

Authors:  J G Cleland; B M Massie; M Packer
Journal:  Eur J Heart Fail       Date:  1999-03       Impact factor: 15.534

2.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

3.  Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Italian Multicenter Cardiomyopathy Study (SPIC) Group.

Authors:  R De Maria; A Gavazzi; A Caroli; R Ometto; A Biagini; F Camerini
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

4.  Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.

Authors:  J T Bigger; W Whang; J N Rottman; R E Kleiger; C D Gottlieb; P B Namerow; R C Steinman; N A Estes
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

5.  An echocardiographic evaluation of patients with idiopathic heart failure.

Authors:  B Andersson; K Caidahl; F Waagstein
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

6.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

7.  Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography.

Authors:  D L Kuchar; C W Thorburn; N L Sammel
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

8.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

9.  Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.

Authors:  S Goldman; G Johnson; J N Cohn; G Cintron; R Smith; G Francis
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

10.  Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy.

Authors:  M E Silverman; M D Pressel; J C Brackett; S S Lauria; M R Gold; S S Gottlieb
Journal:  Am J Cardiol       Date:  1995-03-01       Impact factor: 2.778

View more
  21 in total

1.  The MADIT II and COMPANION studies: will they affect uptake of device treatment?

Authors:  J M Morgan
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

2.  Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.

Authors:  Ralph J van Oort; Mark D McCauley; Sayali S Dixit; Laetitia Pereira; Yi Yang; Jonathan L Respress; Qiongling Wang; Angela C De Almeida; Darlene G Skapura; Mark E Anderson; Donald M Bers; Xander H T Wehrens
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

Review 3.  End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis.

Authors:  Stephen Barclay; Natalie Momen; Steve Case-Upton; Isla Kuhn; Elizabeth Smith
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

4.  Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

Authors:  G Mazzocchi; L Sommese; J Palomeque; J I Felice; M N Di Carlo; D Fainstein; P Gonzalez; P Contreras; D Skapura; M D McCauley; E C Lascano; J A Negroni; E G Kranias; X H T Wehrens; C A Valverde; A Mattiazzi
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

Review 5.  [Prevention of sudden cardiac death].

Authors:  H U Klein
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

6.  [Sleep disordered breathing and nonsustained ventricular tachycardia in patients with chronic heart failure].

Authors:  Ulrich Koehler; Sandra Apelt; Werner Cassel; Olaf Hildebrandt; Christoph Nell; Stephan Ranft; Wolfram Grimm
Journal:  Wien Klin Wochenschr       Date:  2011-11-15       Impact factor: 1.704

Review 7.  Electrophysiological challenges of cell-based myocardial repair.

Authors:  Huei-Sheng Vincent Chen; Changsung Kim; Mark Mercola
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

Review 8.  Advances in devices for cardiac resynchronization in heart failure.

Authors:  Chu-Pak Lau; Serge Barold; Hung-Fat Tse; Kathy Lai-Fun Lee; Hon-Wah Chan; Katherine Fan; Elaine Chau; Cheuk-Man Yu
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 9.  Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems.

Authors:  Jason Pellman; Jing Zhang; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2016-03-18       Impact factor: 5.000

10.  Potential autonomic nervous system effects of statins in heart failure.

Authors:  Tamara B Horwich; Holly R Middlekauff
Journal:  Heart Fail Clin       Date:  2008-04       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.